Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Denali Therapeutics Inc. (DNLI)  
$14.52 0.83 (5.41%) as of 4:30 Fri 7/11


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 143,000,000
Market Cap: 2.08(B)
Last Volume: 0 Avg Vol: 0
52 Week Range: $11.47 - $31.58
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:

   

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  1228
Guru Rank Value     : -1
Guru Occurances    : 2

 

            6 Months   1 Year   2 Year  
 
Company Profile   Denali Therapeutics is a biopharmaceutical company that discovers and develops therapeutics to defeat neurodegenerative diseases. Co.'s clinical-stage programs are: leucine-rich repeat kinase 2 inhibitor program to address Parkinson's disease; enzyme transport vehicle :IDS program, its lead brain-penetrant enzyme replacement therapy, enabled by its enzyme transport vehicle, which is designed to restore iduronate 2-sulfatase, and reduce glycosaminoglycans, both peripherally and in the brain, in patients with mucopolysaccharidosis II; and eukaryotic initiation factor 2 B activator program to address diseases such as amyotrophic lateral sclerosis and frontotemporal dementia.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 0 0 296,265 582,024
Total Sell Value $0 $0 $7,657,639 $13,681,114
Total People Sold 0 0 6 7
Total Sell Transactions 0 0 25 66
End Date 2025-04-13 2025-01-10 2024-07-12 2023-07-13

   
Records found: 475
  Page 1 of 19  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Watts Ryan J. President and CEO   •       •      –    2025-07-09 4 AS $15.00 $7,429,230 D/D (495,282) 253,071 -3%     
   Watts Ryan J. President and CEO   •       •      –    2025-07-09 4 OE $0.68 $520,792 D/D 495,282 748,353     -
   Baker Julian   –       •      –    2025-06-03 3 IO $0.00 $0 I/I 0 3,731,695 10%     
   Schenkein David P Director   –       •      –    2025-06-03 4 A $0.00 $0 D/D 6,037 15,257     -
   Cook Jennifer E. Director   –       •      –    2025-06-03 4 A $0.00 $0 D/D 6,037 26,075     -
   Klein Peter S Director   –       •      –    2025-06-03 4 A $0.00 $0 D/D 6,037 27,533     -
   Flatley Jay T Director   –       •      –    2025-06-03 4 A $0.00 $0 D/D 6,037 16,220     -
   Tessier-Lavigne Marc Director   –       •      –    2025-06-03 4 A $0.00 $0 D/D 6,037 1,886,576     -
   Baker Julian   –       •      –    2025-06-03 4 A $0.00 $0 I/I 21,130 3,415,958     -
   Thornberry Nancy Director   –       •      –    2025-06-03 4 A $0.00 $0 D/D 6,037 24,717     -
   Krognes Steve E. Director   –       •      –    2025-06-03 4 A $0.00 $0 D/D 6,037 31,794     -
   Schuth Alexander O. COFO and Secretary   •       –      –    2025-01-07 4 S $20.81 $60,495 D/D (2,907) 244,308 34%     
   Krognes Steve E. Director   –       •      –    2025-01-07 4 S $20.81 $69,485 D/D (3,339) 25,757 34%     
   Ho Carole Chief Medical Officer   •       –      –    2025-01-07 4 S $20.81 $60,495 D/D (2,907) 175,673 34%     
   Watts Ryan J. President and CEO   •       •      –    2025-01-07 4 S $20.81 $159,197 D/D (7,650) 253,071 34%     
   Schuth Alexander O. COFO and Secretary   •       –      –    2025-01-06 4 S $20.22 $247,796 D/D (12,255) 247,215 30%     
   Ho Carole Chief Medical Officer   •       –      –    2025-01-06 4 S $20.22 $247,796 D/D (12,255) 178,580 30%     
   Watts Ryan J. President and CEO   •       •      –    2025-01-06 4 S $20.22 $591,759 D/D (29,266) 260,721 30%     
   Watts Ryan J. President and CEO   •       •      –    2025-01-03 4 A $0.00 $0 D/D 54,180 289,987     -
   Schuth Alexander O. COFO and Secretary   •       –      –    2025-01-03 4 A $0.00 $0 D/D 54,180 259,470     -
   Ho Carole Chief Medical Officer   •       –      –    2025-01-03 4 A $0.00 $0 D/D 54,180 190,835     -
   Sato Vicki L Director   –       •      –    2025-01-02 4 AS $20.91 $64,403 D/D (3,080) 107,976 -33%     
   Krognes Steve E. Director   –       •      –    2024-12-31 4 AS $20.25 $607,500 D/D (30,000) 29,096 -30%     
   Schuth Alexander O. COFO and Secretary   •       –      –    2024-12-27 4 OE $5.28 $35,418 D/D 6,708 205,290     -
   Ho Carole Chief Medical Officer   •       –      –    2024-11-25 4 OE $0.68 $12,135 D/D 17,845 136,655     -

  475 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 1 of 19
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed